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The sigB operon ofBacilus subtilis encodes (9' plus three additional proteins (RsbV, RsbW, and RsbX) that
regulate c9B activity. Using an anti-&B monoclonal antibody to monitor the levels of (9B protein, PspAc to
control the expression of the sigB operon, and a ctc-lacZ reporter system to monitor crB activity, we observed
that the rsbV and rsbW products control (9B activity at the ctc promoter independently of their effects on (9B
levels. In contrast, RsbX was found to have no effect on expression of ctc when the sigB operon was controlled
by PSPAc. The data are consistent with RsbV and RsbW being regulators of (9B activity and RsbX acting
primarily as a negative regulator of sigB operon expression. Evidence that stationary-phase induction of the
c9B-dependent ctc promoter is accomplished by a reduction in RsbW-dependent inhibition of crB activity is also
presented. In addition, Western blot (immunoblot) analyses of sigB operon expression demonstrated that (9B
accumulation is coupled to the synthesis of its primary inhibitor (RsbW). This finding is consistent with RsbW
and (rB being present within the cell in equivalent amounts, a circumstance that would permit RsbW to directly
influence (9B activity by a direct protein-protein interaction.
Ten different sigma factors have been identified in Bacillus
subtilis. Each of these proteins confers a novel promoter
specificity on the RNA polymerase holoenzyme which car-
ries it. Four of the sigma factors (Un, crF, (rG, and orK) are
synthesized only when B. subtilis undergoes sporulation
(16-18, 27, 28, 32, 38, 40, 41). They are essential for the
expression of sporulation genes but are dispensable to veg-
etativel growing bacteria. The remaining six sigma factors
(arA, an ,,oa ',&, and Un) are found in vegetatively
growing bacteria, in which they participate in the expression
of genes involved in diverse activities. The most abundant of
the vegetative sigma factors is 0A. rA transcribes the bulk of
the cell's housekeeping genes as well as several early sporu-
lation genes (12, 21, 29). is required for the transcription
of competence and early sporulation genes (1, 13). and UL
direct the transcription of chemotactic and degradative en-
zyme operons, respectively (10, 22, 34). The functions of
and uC are unknown, but their low abundance argues that
they are likely to participate in the expression of very
specialized regulons. nrc is known only by its activity in in
vitro transcription reactions (25). In contrast, has been
characterized both biochemically and genetically and shown
to be nonessential for both growth and sporulation (6, 15, 19,
20).
An analysis of the DNA region encoding (sigB) re-
vealed that sigB is the third gene of a four-gene operon: rsbV
rsbW sigB rsbX (the rsb genes were previously designated
orf), principally transcribed from a promoter that is recog-
nized by e-containing RNA polymerase (Een) (15, 26). The
downstream gene of the sigB operon (rsbX) is believed to be
a negative regulator of either Un' activity or its synthesis in
that null mutations in this gene heighten expression from
Un-dependent promoters (4, 7, 23, 26). The rsbV and rsbW
products are also regulators of (4, 7). These proteins have
significant homology to the predicted amino acid sequence of
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SpoIIAA and SpoILAB, regulators of the B. subtilis sporu-
lation-specific sigma factor Un' (26). Genetic evidence sug-
gests that RsbW and SpoIIAB are inhibitors of their respec-
tive sigma factors (4, 7, 37), with the other member of the
regulatory pair (RsbV and SpoIIAA) functioning in the
release of its particular sigma factor from this inhibition. In
vitro reconstitution experiments indicate that RsbW inhibits
by binding to it and preventing its association with RNA
polymerase (5). Similar findings were obtained by Duncan
and Losick in a study of SpoIIAB inhibition of (14).
The effects of null mutations in rsbV, rsbW, and rsbX on
the activity of Un'-dependent promoters suggested a model in
which RsbW is the primary inhibitor of Un-dependent tran-
scription with RsbV capable of counteracting RsbW's nega-
tive control but normally prevented from doing this by the
rsbX gene product (4).
In the present study, we continue our examination of the
roles of RsbV, RsbW, and RsbX in controlling the levels and
activity of through experiments in which sigB operon
expression is controlled by an inducible promoter (PspAC),
abundance is directly monitored by Western blot (immu-
noblot) analyses using an anti-Un monoclonal antibody as a
probe, and activity is measured at the Un-dependent ctc
promoter by means of a ctc::lacZ reporter system. In this
experimental system, we confirmed that it is the activity of
RsbW and not the level of that is the critical element
influencing the level of Ur-dependent promoter activity.
Consistent with our biochemically defined mechanism for
RsbW control of (5) and the previous in vivo experiments
of Boylan et al. (7), we observed that RsbV and RsbW
regulate the expression of ctc independently of their influ-
ence on levels. This is not true of RsbX. The loss of RsbX
resulted in elevated levels and heightened ctc transcrip-
tion when the sigB operon was expressed from its normal
Un-dependent promoter but had no effect on ctc expression
when the sigB operon was expressed from PspAc- These
data suggest that the RsbV-RsbW and RsbX regulators
control different aspects of Un. RsbV and RsbW participate
in directly regulating Un's activity, while RsbX appears to
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function primarily as a negative regulator of sigB operon
expression.
MATERIALS AND METHODS
Bacterial strains and culture media. All B. subtilis strains
constructed for this project were derived from PY22, which
was originally obtained from P. Youngman (University of
Georgia). Escherichia coli BL21(DE3)(pLysS), constructed
by F. W. Studier and B. A. Moffatt, (39), was obtained from
V. Deretic (University of Texas Health Science Center, San
Antonio). Cells were grown in Luria broth (LB) (33) or Difco
sporulation medium (DS medium) (36) as previously de-
scribed (4). Plasmid pSI-1 (PspAc) was from D. Henner
(Genentech, South San Francisco, Calif.). pTet-I is pSI-1
(44), cut with EcoRI and PstI to remove the SPAC promoter
and carrying instead a 4.6-kbp DNA fragment of Tn916 (9) at
this site. The fragment contains the tetM gene of Tn916
which was initially cloned into the multiple cloning site of
pUC19 (43) as a HincII fragment by D. LeBlanc (University
of Texas Health Science Center, San Antonio). The 4.6-kbp
segment was cut out of this intermediate plasmid (pTC-2) as
an EcoRI-PstI fragment for cloning into pSI-1. pUS19 was
constructed by cloning a 1.1-kbp ClaI-NdeI DNA fragment
encoding spectinomycin resistance from pDL273 (31) into
AccI-NdeI-cut pUC19. pUS19 replicates in E. coli and
confers spectinomycin resistance (100 ,ug/ml) on E. coli and
B. subtilis. Stable maintenance of spectinomycin resistance
in B. subtilis requires recombination of the plasmid into the
B. subtilis chromosome.
B. subtilis transformations. Plasmid and chromosomal
DNA was transformed into B. subtilis which had been made
competent by the method of Yasbin et al. (45). Transfor-
mants were selected on LB agar plates containing 5 ,ug of
chloramphenicol per ml, 5 ,ug of kanamycin per ml, 1 ,ug of
erythromycin per ml, or 100 ,ug of spectinomycin per ml
where appropriate.
Preparation of &rB antigen for antibody production. In order
to overexpress &B antigen for antibody production, a 700-bp
DNA fragment that encodes the carboxy-terminal two-thirds
of or (4) was cloned into an E. coli expression plasmid
(pRSET; Invitrogen, San Diego, Calif.). This resulted in a
translational fusion of sigB at codon 85 to a phage T7 gene
which had been modified by the manufacturer to include a
polyhistidine metal binding domain in its product. The
recombinant plasmid (pRSET::AsigB) was transformed into
an E. coli strain (BL21) which carries the gene for T7 RNA
polymerase under the control of an IPTG (isopropyl-P-D-
thiogalactopyranoside)-inducible lac UVR-5 promoter. T7
RNA polymerase is rifampin resistant. Figure 1A depicts an
autoradiogram of sodium dodecyl sulfate (SDS)-lysed
pRSET::AsigB cells that had been fractionated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) following
pulse-labeling for 5 min with 50 ,uCi of [35S]methionine per
ml in M-9 glucose minimal medium (33). The synthesis of the
T7 RNA polymerase was either uninduced (lane 3) or
induced in the presence of rifampin (lanes 1 and 2). Figure
1B illustrates a Coomassie blue-stained SDS-polyacrylamide
gel of total protein present in BL21 carrying pRSET::AsigB
either uninduced (lane UI) or 2 h after IPTG induction (lane
I). A single protein with the anticipated mobility of the &B
antigen was synthesized in the rifampin-treated cultures
(Fig. 1A, lanes 1 and 2). A protein of this mobility also
became the principal protein in the induced cell extract (Fig.
1B). This extract was centrifuged for 15 min at 10,000 x g,
whereby the bulk of the &e antigen was found to pellet with
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FIG. 1. Synthesis and purification of &e antigen. (A) E. coli
BL21 carrying pRSET::AsigB was grown in minimal medium and
pulse-labeled with [35S]methionine as described in Materials and
Methods either before induction of T7 RNA polymerase (lane 3) or
5 min (lane 2) and 20 min (lane 1) after induction in the presence of
rifampin (200 pg/ml). Cell lysates were fractionated by SDS-PAGE,
and radioactively labeled proteins were detected by autoradiogra-
phy. The migration of molecular weight standards in this gel system
is shown on the left. The arrowhead to the right of the panel
indicates the position of the &e antigen. (B) The protein profile of
BL21(pRSET::AsigB) cells was determined by fractionating cell
lysates by SDS-PAGE and staining the resulting gels with
Coomassie blue. Cells were harvested for analysis either prior to
(UI) or 2 h after (I) the addition of IPTG to induce T7 RNA
polymerase. The arrowhead indicates the position of the &B antigen.
(C) SDS-PAGE analysis of fractions obtained during the purification
of the (rB fusion protein from the pellet fraction of a crude lysate
(lane P) of BL21(pRSET::AsigB). The fusion protein was adsorbed
to a nickel-nitrilotriacetic acid column in buffer containing 6 M
guanidine, washed with buffer containing 8 M urea, and eluted from
the column with a pH gradient from 8.0 to 5.0 in 8 M urea. Material
which failed to bind to the column is shown in lane F. Molecular
weight markers are shown in lane M.
the cell debris. The pellet from an induced 1-liter culture was
resuspended in 10 mM Tris (pH 8.0)-0.1 M NaH2PO4-6 M
guanidine HCl and applied to a 2-ml nitrilotriacetic acid
resin-Ni2+ column (Qiagen, Studio City, Calif.). The column
was washed with 10 mM Tris (pH 8.0)-0.1 M NaH2PO4-8 M
urea (pH 8.0) and eluted with a pH gradient (pH 8.0 to 5.0)
in the 8 M urea buffer. Figure 1C illustrates the column
purification step. The oP antigen in the crude cell pellet (P) is
significantly reduced in the column flowthrough (F) but is
recovered from the column by low pH elution as a virtually
homogeneous protein. On the basis of Coomassie blue
protein assays, we estimate that 5 to 7 mg of cr1 antigen is
obtained from a 1-liter culture.
Monoclonal antibody production. Hybridomas were pro-
duced in BALB/c mice as was done previously (42). Super-
natants from wells containing proliferating hybridomas were
screened for antibody production in enzyme-linked immu-
nosorbent assays (ELISAs) using purified crB antigen in the
assay. Hybridomas demonstrating antibody activity for &B
protein were further screened in Western blot analyses by
using the supernatants to probe crude B. subtilis cell extracts
prepared from strains that either synthesized (PY22) or
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could not synthesize (BSA80 sigB314) &e (4). Hybridomas
which produced an antibody that bound to a protein of the
proper size in the extract from the sigB strain but not in that
from the mutant (sigB314) strain were single cell cloned by
limiting dilution.
Mutagenesis. Oligonucleotide-directed mutagenesis was
employed to remove the &3-dependent promoter of sigB in
an M13mpl8 clone (43) carrying either the rsbV312 or the
rsbW313 mutation (4) on a 1.9-kbp PstI fragment (Fig. 2). An
oligonucleotide (ITCAAATCACTAGTTAACCTLlTCTCC
GCAA) complementary to the region 15 bases upstream and
15 bases downstream of nucleotides -5 to -33 relative to
the sigB transcriptional start site was synthesized and used
as described previously (4) to delete the intervening 28
nucleotides. The mutagenic oligonucleotide was also de-
signed to create a unique HpaI site at the junction of the
deletion (A28HpaI, Fig. 2). The identities of the mutant
clones, selected by the method of Kunkel (30), were verified
by restriction endonuclease mapping and DNA sequencing.
The 1.9-kbp PstI fragment from the mutant clones was
ligated into the PstI site of pAK39 (4) to form plasmids
pV312A28 and pW313A28 (Fig. 2). The SPAC promoter (44),
carried on a 134-bp EcoRV-SmaI DNA fragment, was
cloned into the unique HpaI site in these plasmids, forming
pVSPAC and pWSPAC (Fig. 2). These plasmids now con-
tain modified sigB operons in which the &3-dependent pro-
moter has been replaced by PspAC. The EcoRI-PstI region of
pAK39 (Fig. 2) was originally constructed by inserting a
kanamycin resistance gene into a fragment of B. subtilis
DNA immediately upstream of the sigB operon (4). The PstI
site of pAK39 into which the 1.9-kbp PstI fragments of
PBA28 DNA were inserted is the site at which these frag-
ments are normally joined in the B. subtilis chromosome. We
have therefore reconstructed the region upstream of the
mutations, including approximately 1 kbp of DNA upstream
of the kanamycin resistance gene. Linearization of each of
these plasmids (pVSPAC and pWSPAC) with ScaI (Fig. 2),
followed by its transformation into B. subtilis, yields kana-
mycin-resistant transformants which have a high probability
of recombining both PspAc and the mutant rsbV and rsbW
alleles into the B. subtilis chromosome. rsbX: :spec was
constructed by linearizing pML7 at its unique ClaI site
within rsbX and cloning into it a Specr determinant that had
been excised from pUS19 as a 1.4-kbp HpaII DNA frag-
ment. The resulting plasmid, pML7/X::Spec, was linearized
with ScaI and transformed in B. subtilis, in which spectino-
mycin-resistant clones would carry the rsbX::spec allele.
Western blot analysis. Crude cell extracts were prepared
from E. coli or B. subtilis and fractionated by SDS-PAGE
(12.5% acrylamide) as previously described (42). Following
electrophoretic transfer to nitrocellulose and blocking of the
nitrocellulose with BLOTTO, the immobilized protein bands
were probed with anti-cB monoclonal antibody. Bound
antibody was visualized with an alkaline phosphatase-con-
jugated goat immunoglobulin against mouse immunoglobulin
(HyClone Laboratories, Inc.).
1-Galactosidase assays. Cells were harvested from cultures
and frozen at -70°C until further use. In some experiments,
0-galactosidase activity was detected in lysates prepared by
resuspending cell pellets in 5 ml of Z buffer (33) and
passaging the cells through a French pressure cell at 15,000
lb/in2. Debris was removed by centrifugation at 10,000 x g
for 10 min. Dilutions of the supernatants were assayed for
P-galactosidase activity by the method of Miller (33). The
amount of protein present in the extracts was quantitated
with the Bio-Rad protein assay reagent as recommended by
the manufacturers. 13-Galactosidase activity was calculated
as the optical density at 420 nm x 100/mg of protein in a
30-min incubation at 370C. In other studies, 13-galactosidase
activity was determined by the method of Kenney and
Moran (28), with the levels calculated as Miller units.
DNA sequencing. DNA sequencing was performed by the
Sanger method with Sequenase reagents (U.S. Biochemical
Corp.) and the protocol provided by the manufacturer.
RESULTS
Specificity of anti-cr& monoclonal antibody. As described
above, &r antigen was synthesized in E. coli and used to
immunize mice for hybridoma production. After spleen
cell-myeloma fusion, selection, and screening by ELISA,
supernatants from putative anti-uB-secreting clones were
tested for specificity in Western blot analyses and single cells
were cloned. Figure 3 illustrates the Western blot analyses
for the antibody used in this study. Panel A depicts crude
cell extracts from E. coli BL21 with or without
pRSET::AsigB, fractionated by SDS-PAGE and either
stained with Coomassie blue or transferred to nitrocellulose
and probed with anti-o- antibody. In the data presented, 10
times more extract from the plasmidless strain than from the
strain carrying pRSET::AsigB was analyzed. No detectable
antibody bound to the proteins extracted from BL21 (Fig.
3A, lane 3); however, the antibody did react strongly to two
protein bands in the extract from the pRSET::AsigB-con-
taining strain (Fig. 3A, lane 4). The faster-migrating of the
two bands had the mobility of the &e antigen. We suspect
that the more slowly migrating band is an aggregated form of
the &e antigen which was not disrupted during the sample
preparation. We base this notion on its absence from the
plasmidless E. coli extract and the observation that the o'
antigen aggregates readily following induction in BL21.
We next tested our antibody on B. subtilis extracts to
ensure that the probe recognizes an epitope on &e that is not
shared with other B. subtilis proteins. To do this, we
performed Western blot analyses on crude B. subtilis ex-
tracts prepared from cells that either synthesized crB (PY22)
or contained a sigB allele (BSA80 sigB314) (4) with a
frameshift mutation which terminates translation near the &e
amino terminus. We observed that, although the monoclonal
antibody detected no proteins in the extract from the sigB314
strain (Fig. 3B, lane 3), it recognized a single protein with the
apparent mobility of &e in the extract prepared from the
wild-type strain (Fig. 3B, lane 4). We conclude that this
antibody is highly specific for (r and can be used to monitor
eB in B. subtilis extracts.
Response of &r levels to medium and growth state. The
principal promoter of the sigB operon is transcribed by
&3-containing RNA polymerase (4, 15). Two additional
re-dependent transcription units are known (csbA and ctc)
(8, 24). Both ctc and csbA are induced approximately
fivefold by a cr-dependent mechanism at the end of expo-
nential growth in LB medium supplemented with glucose
and glutamine but are elevated only slightly by entering
stationary phase in DS medium (8, 24). Given the induction
profile of ctc and csbA, it would be anticipated that sigB
transcription, depending as it does on a &3-dependent pro-
moter, would also fluctuate in response to growth state and
medium. Our previous data suggested, however, that the
sigB operon's &'-dependent promoter doesn't respond in an
identical manner to the ctc and csbA promoters (4). We
observed only a twofold increase in sigB-specific RNA in
both LB and DS media when B. subtilis entered stationary
VOL. 175, 1993
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FIG. 2. Construction of plasmids pVSPAC and pWSPAC. PstI-generated, 1.9-kbp DNA fragments, carrying the sigB operon with either the
rsbV312 or the rsbW3l3 allele, were subjected to mutagenesis as described in Materials and Methods to delete the operon's &3-dependent
promoter and cloned into the PstI site of pAK39 (4). pAK39 contains an EcoRI-PstI fragment that carries a Kmr gene within the DNA region
immediately upstream of the 1.9-kbpPstl fragment in the B. subtilis chromosome which becomes rejoined to the 1.9-kbp fragment in the resulting
plasmids (pV312A28 and pW313A28). The plasmids were then opened at a unique HpaI site that was placed in the sigB promoter region during
the mutagenesis, and a 135-bp EcoRV-SmaI fragment containing PspAc (44) was cloned into this site. The resulting plasmids (pVSPAC and
pWSPAC) contain mutant sigB operons under the control of PSPAC with a selectable Kn'r gene immediately upstream of the operon.
phase (4). The differences in the medium dependence and the
degree of induction of the sigB and ctc-csbA operons suggest
that it is unlikely that the profile of ctc and csbA induction
merely reflects changes in &e levels. Instead, an additional
level of control is likely to exist at ctc and csbA. The
availability of an anti-&3 antibody permitted us to monitor
changes in the level of &e in response to medium or
state-of-growth changes which affected ctc and csbA expres-
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FIG. 3. Western blot reactions of the anti-4B monoclonal anti-
body. Extracts from E. coli (A) and B. subtilis (B) were prepared as
described in Materials and Methods, fractionated by SDS-PAGE,
and either stained with Coomassie blue (lanes 1 and 2) or transferred
to nitrocellulose and probed with the anti-acB monoclonal antibody
(lanes 3 and 4). For panel A, 100 pLg of protein from BL21 (lanes 1
and 3) or 10 Fg of protein from BL21(pRSET::AsigB) (lanes 2 and 4)
was loaded. For panel B, 200 pg of protein from BSA80 (sigB314)
(lanes 1 and 3) and 100 pg of protein from PY22 (lanes 2 and 4) was
loaded. The arrowheads indicate the positions of the r'3 antigens.
sion. We therefore measured the relative abundance of &'
during vegetative growth and stationary phase in LB (glu-
cose-glutamine) (ctc-inducing) or DS (non-ctc-inducing) me-
dium. As can be seen in Fig. 4, the amounts of &e in both the
DS medium- and the LB-grown cultures are very similar
during vegetative growth (lane 1) with parallel small in-
creases when the cells enter stationary phase (lane 2). On the
basis of this experiment, e1 appears to be most abundant
when B. subtilis is cultured past the end of exponential
growth and accumulates to similar levels regardless of
whether the medium is sporulation inhibiting (LB with
glucose-glutamine) or sporulation promoting (DS). The com-
parable levels of &' found in both LB and DS medium
substantiate the previous finding (4) and demonstrate that
the observed LB-dependent increase in ctc and csbA gene
expression is unlikely to be solely due to increases in a1
levels.
Accumulation of crB in B. subtilis strains with mutations in
the sigB operon. We and others have observed that null
mutations in two of the genes of the sigB operon (rsbV and
sigB) eliminated expression from the ctc and sigB operons'
o-"-dependent promoters while null mutations in the remain-
DSM 0:t l -lE
FIG. 4. Effects of the orfV,312, rsbW313, and rsbX:.:pAK17 mu-
tations upon accumulation of a~3. Crude extracts containing 100 pxg
of total protein were prepared from strains BSA46 (wild type; lanes
1 and 2), BSA73 (rsbV312; lanes 3 and 4), BSA88 (rsbW3l3; lanes 5
and 6), and BSA64 (~rbX:-:pAK17; lanes 7 and 8); fractionated by
SDS-PAGE; transferred to nitrocellulose; and probed with the
anti-c" monoclonal antibody. The cells were grown in LB supple-
mented with 5% glucose and 0.2% glutamine or in DS medium
(DSM) with samples harvested from logarithmically growing (lanes
1, 3, 5, and 7) and stationary-phase (lanes 2, 4, 6, and 8) cultures.
ing two genes (rsbW and rsbX) dramatically increased the
activity of these promoters (4, 6, 7, 15, 23). Using the antis'
antibody in Western blot analyses, we can directly observe
the changes in &reabundance that occur in the rsbV, rsbW,
and rsbX mutant strains and compare these changes with the
effects of these mutations on ctc expression. Crude cell
extracts were prepared from mid-log- or stationary-phase B.
subtilis cultures and analyzed by Western blot for6an8 levels.
Both the rsbW (BSA88; Fig. 4, lanes 5 and 6) and rsbX
(BSA64; lanes 7 and 8) mutant strains accumulate substan-
tially more Wsprotein than that found in the wild-type strain
(BSA46; lanes 1 and 2), while the rsbV3l2 strain (BSA93;
lanes 3 and 4) lacks detectable o'. The results are similar
regardless of whether the extracts were prepared from
strains grown in LB or in DS medium (Fig. 4). This is not the
case for ctc expression. The level of ctc promoter activity in
the strains is presented in Table 1. Although there is a good
correlation among the effects of the rsbV, rsbW, and rsbX
mutations on 7 abundance and ctc activity, there is an
LB-dependent enhancement of ctc induction that was not
seen as a change inl protein levels. These results are
consistent with RsbV, RsbW, and RsbX being regulators of
r synthesis and support the notion that there is an addi-
tional medium-dependent regulatory element operating at
the srai-dependent ctc promoter that does not control the
LB-dependent promoter of sigB.
Expression of &Bfrom a PspAc-controlled sigB operon.
Genetic and biochemical evidence argue that the RsbV-
RsbW proteins compose a regulatory device for controlling
eB activity and that RsbX is an additional regulator that
functions at a point upstream of RsbV-RsbW in the pathway
of &- control (4, 5, 7). In order to verify in vivo that RsbV
12 34 56 78
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TABLE 1. ctc-dependent 0-galactosidase activity in wild-type
(BSA46), rsbV312 (BSA73), rsbW313 (BSA88),
and rsbX::pAK17 (BSA64) strains
P-Galactosidase activity witha:
LB plus glucose and DS medium
Strain glutamine
Mid-log Stationary Mid-log Stationary
phase phase phase phase
BSA46 5 23 4 8
BSA73 0.3 0.17 0.6 0.4
BSA88 51 129 18 35
BSA64 118 197 56 92
a P-Galactosidase activity is calculated as optical density at 420 nm x
100/mg of protein in a 30-min assay.
and RsbW control oa' activity, independent of their effect on
&e levels, and to ask whether RsbX could also be a modu-
lator of &e activity, we monitored the effects of these
mutations on ctc expression in a B. subtilis strain in which
sigB operon expression no longer depended on &e. To do
this, we deleted a critical element of the &3-dependent
promoter ofsigB and replaced it with the SPAC promoter as
described in Materials and Methods. The reengineered op-
erons were then introduced by transformation into a B.
subtilis strain (BSA46) which is lysogenic for an SPOI pro-
phage bearing a ctc::lacZ translational fusion (24) and carries
a source of the E. coli lacI gene product on a multicopy
plasmid (pTet-I). In BSA46, PspAC, and hence sigB, is
inducible by the addition of IPTG to the culture medium.
The termination codon of rsbV is superimposed on the
initiation codon of rsbW (26). In addition, rsbW and sigB
overlap by 13 codons (26). These overlapping regions
prompted Kalman et al. to propose that translation of sigB
operon genes might be coupled (26). Given the possibility of
translational coupling, we performed a preliminary experi-
ment to ask whether the rsbV312 and rsbW313 alleles, which
contain frameshift mutations near the amino termini of their
coding regions (4), affect the accumulation of &e in a B.
subtilis strain in which their potential effects on sigB tran-
scription would not mask a posttranscriptional influence. B.
subtilis cultures containing PspAc-driven sigB operons,
specifying wild-type or mutant rsbV or rsbW alleles, were
induced with IPTG and analyzed for &r levels by Western
blot. Figure 5 shows induction of &r protein from sigB
operons with wild-type (BSA105, lanes 7 to 9), rsbV312
(BSA106, lanes 4 to 6), or rsbW313 (BSA107, lanes 1 to 3)
alleles. There was induction in all three cases, but the level
of &e protein found in the rsbW313-containing strain was less
than 10% of that seen in the wild-type and rsbV312 strains. If
the rsbW313 and wild-type extracts are probed with anti-
RsbV antibody rather than anti-e' antibody, comparable
levels of this operon product can be seen in both extracts
(data not shown). The drop in &e but not RsbV in the
rsbW313-containing strain is consistent with the low level of
protein seen in this strain being due to a posttranscrip-
tional effect of the rsbW313 allele on o,' accumulation rather
than an unforeseen transcriptional defect at this strain's
SPAC promoter. The latter circumstance would have re-
duced all of the operon's products. Efficient synthesis of &r
apparently requires the translation of rsbW but not rsbV.
We next examined the effect of inducing sigB operons
containing either wild-type or mutant alleles on the activity
of the &'-dependent etc promoter. Boylan et al. in a similar
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FIG. 5. cr accumulation in A28::PSPAC strains. Crude extracts
from BSA105 (A28::PSPAC, pTet-I; lanes 7 to 9), BSA106 (rsbV312
A28::PSPAC, pTet-I; lanes 4 to 6), and BSA107 (rsbW313 A28::PSPAC,
pTet-I; lanes 1 to 3) were prepared from cells grown in LB
supplemented with 5% glucose and 0.2% glutamine or in DS medium
(DSM). Samples containing 100 ,ug of total protein were fractionated
by SDS-PAGE, transferred to nitrocellulose, and probed with the
anti-&3 monoclonal antibody. Samples in lanes 3, 6, and 9 were
derived from cultures prior to induction. Samples in lanes 2, 5, and
8 were harvested 30 min after induction with 1 mM IPTG during
vegetative growth while samples in lanes 1, 4, and 7 were harvested
from the induced cultures approximately 4 h later when the cultures
had been in stationary phase for 1.0 h.
study had noted that appreciable levels of ctc expression
were observed only if transcription of the sigB operon was
initiated near the end of exponential growth (7). We there-
fore induced our cultures at different times during growth or
stationary phase to ensure that the physiological state of the
cultures was not contributing to the phenotype that we
would attribute to the mutant allele under study. Figure 6
illustrates these experiments with the ctc::lacZ induction
curves plotted above the growth curves of the cultures being
induced. The points on the ctc expression plots at which the
IPTG-induced cultures diverge from the uninduced culture
correspond to the times at which IPTG was added to those
cultures. Figure 6A depicts the expression of ctc in an
IPTG-inducible strain (BSA105) that synthesizes wild-type
sigB gene products. Consistent with the findings of Boylan et
al. (7), etc expression rose over the uninduced levels only
when the sigB operon was induced at the end of exponential
growth. Induction of the sigB operon 1 h after the onset of
stationary phase gave no appreciable elevation of ctc-depen-
dent ,B-galactosidase levels over that seen in the uninduced
culture (data not shown). We next performed the experiment
with a strain of B. subtilis in which the PSPAc-driven sigB
operon contained a null mutation in rsbX (BSA123;
rsbX::spec). This experiment, illustrated in Fig. 6B, revealed
that the absence of the rsbX gene product had no effect on
ctc expression when the sigB operon was expressed from
PSPAC. This is in contrast with the dramatic increase in ctc
expression following the loss of RsbX from a strain in which
the sigB operon is expressed from its normal promoter
(Table 1). The absence of such an increase in BSA123 argues
that RsbX is a regulator of the sigB operon expression and
not a significant controlling element in the activation of &rB
itself. In contrast to the result obtained with the rsbX
mutant, the absence of RsbW had a marked effect on etc
expression (Fig. 6C). As was found in the previous study (7),
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FIG. 6. ctc expression following induction of PspAc-controlled sigB operons. Cultures of BSA105 (PBA28::PSPAC, pTet-I) (A), BSA123
(rsbX::spec PBA28::PSPAC, pTet-I) (B), BSA107 (rsbW313 PBA28::PSPAC, pTet-I) (C), and BSA125 (rsbW313 rsbX::spec PBA28::PSPAC,
pTet-I) (D) were grown in LB supplemented with 5% glucose-0.2% glutamine. Samples were taken from uninduced cultures (- -) or
portions of the cultures in which the PspAc promoter was induced by the addition of IPTG to 1 mM (0, 0, and A) and assayed for
ctc-dependent P-galactosidase production (28). IPTG was added to the cultures at the points on the graphs where the induced culture plots
diverge from the plots of the uninduced cultures. The P-galactosidase levels are recorded as Miller units (33). The growth curve of the
uninduced culture is depicted below each P-galactosidase expression plot to illustrate the growth stage of the culture at the time of IPTG
addition. The optical densities of the cultures were measured at 540 nm.
induction of a sigB operon which lacks a functional rsbW
gene results in heightened ctc expression that commences
immediately after the induction of the sigB operon. The
absence of RsbW thus frees ctc expression from the need to
induce sigB at a particular time in the growth cycle. This was
first reported by Boylan et al. (7), who suggested that
stationary-phase induction of ctc is channeled through a
release from RsbW-dependent inhibition. This would be the
simplest interpretation of these results; however, it is for-
mally possible that the stationary-phase activation of &B
could occur by its release from an unknown inhibitor. The
relatively modest induction which occurs at stationary phase
(Fig. 6A) could still be occurring in the rsbW313 mutant but
be masked by the very high levels of &e activity in this strain
(Fig. 6C). As expected from the previous result (Fig. 6B), the
ctc induction profile of the rsbW313 rsbX: :spec double
mutant, BSA125 (Fig. 6D), is similar to that of the rsbW313
single mutant. Induction of a PsPAc-driven sigB operon in a
strain (BSA106) containing a null rsbV allele results in no
detectable ctc expression regardless of when in the growth
cycle the sigB operon was induced (data not shown). Thus,
the loss of RsbV or RsbW but not RsbX significantly affects
the activity of &e at the ctc promoter when control of the
sigB operon is removed from its influence.
In order to confirm that the changes in ctc expression that
were observed in the experiments whose results are illus-
trated in Fig. 6 were due to differences in &e activity and not
its abundance, samples of the cultures were taken before or
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FIG. 7. a1B in PspAc-controlled operons. One-milliliter samples
of the cultures analyzed for Fig. 6 were lysed and processed for
SDS-PAGE as described by Arnosti et al. (2) and analyzed for a1
protein as for Fig. 3. Lanes A to E are samples from BSA106 (Fig.
6C), lanes F to J are samples from BSA105 (Fig. 6A), lanes K to 0
are samples from BSA125 (Fig. 6D), and lanes P to T are samples
from BSA123 (Fig. 5B). The first sample in each series (i.e., lanes A,
F, K, and P) was taken from an uninduced culture at an optical
density at 540 nm of 1.0. The remaining four lanes represent samples
from IPTG-induced cultures harvested 1 h after the addition of
IPTG. The first three induced culture lanes in each series (i.e., B to
D, G to I, L to N, and Q to S) represent the cra synthesis that
followed the IPTG additions depicted in Fig. 6. The fourth lane in
each series (E, J, 0, and T) depicts the induced aB3 synthesis that
occurs if IPTG is added 1 h later than the previous time of addition.
1 h after induction of the sigB operon and subjected to
Western blot analysis using the anti-a3 monoclonal antibody
as a probe. In the absence of IPTG, the ar3 level was below
that detectable in the assay (Fig. 7, lanes A, F, K, and P).
Induction of sigB during exponential growth resulted in a
greater level of (JB synthesis than that observed when the
operon was induced during stationary phase (e.g., lanes G
and H versus lanes I and J). The presence of the rsbX::spec
mutation had no effect on ae levels (e.g., lanes G to J versus
lanes Q to T), but the presence of the rsbW313 mutation
reduced the levels of below that seen in a strain with a
functional rsbW allele (e.g., lanes B to E versus lanes G to J).
When the level of ar3 protein present in each of the cultures
is compared with the culture's level of ctc expression, there
is little direct correlation. ctc expression is at its lowest in
the culture with one of the highest levels of &e (i.e., BSA105
induced during vegetative growth [lane G]) and at a high
level in the culture with one of the lowest levels of ar3 (i.e.,
BSA106 induced at stationary phase [lane D]). It would
appear that it is not the abundance of a3 itself but its activity
state that determines the level of ctc induction. We conclude
from these experiments and previous studies that RsbV and
RsbW are regulators of (rB activity while RsbX appears to be
a negative regulator of the sigB operon and not a direct
inhibitor of activity under the conditions that we em-
ployed.
DISCUSSION
In earlier studies, we and others generated null mutations
in the four open reading frames of the sigB operon and
analyzed the consequences of these mutations on a'3-depen-
dent transcription (4, 7). These analyses indicated that rsbW
and rsbX encode negative regulators of o- while rsbV
specifies a positive regulator which functions to counteract
the negative regulation of RsbW. RsbW-dependent inhibi-
tion of e' appears to involve a direct association between
RsbW and which prevents ae from binding to RNA
polymerase (5). Given that RsbW and ar3 form a complex,
RsbV presumably acts by disrupting or preventing formation
of this complex.
The notion that RsbV and RsbW control &B activity and
not merely its synthesis is supported by the present study
and the experiments of Boylan et al. (7) in which rsbV and
rsbW gene products are shown to affect the transcription
from a &r3-dependent promoter even when the expression of
the sigB operon is placed under the control of PspAc. In our
study, where the levels of orB protein were monitored, we
found little correspondence between the expression of ctc
and the levels of &B protein. In the absence of RsbW, high
levels of ctc expression occur even at relatively low &B
levels, while a lack of RsbV prevents the expression of ctc
even when o-B levels are abundant. We also verified the
observation, initially made by Boylan et al. (7), that ctc is
expressed during logarithmic growth only by the induction of
a sigB operon that lacks a functional rsbW gene product.
Presumably, a substance present in vegetative cells stimu-
lates RsbW-dependent inhibition. In other studies (3), we
found that dilution of a stationary-phase culture, which was
expressing ctc, into fresh medium results in a rapid RsbW-
dependent fall in the level of ctc expression. Apparently, the
hypothetical substance that stimulates RsbW-dependent in-
hibition can inactivate previously active &e.
The previously noted difference in the activities of the
&3-dependent promoters of sigB and ctc was also observed
in the present study. ctc is induced approximately 5- to
10-fold at the end of the exponential-growth phase only in
LB (glucose-glutamine) medium (4, 7, 24) while sigB is
induced twofold at stationary phase regardless of the me-
dium (4). These findings are consistent with two levels of
regulation at the ctc promoter, a medium-dependent compo-
nent that does not have an obvious counterpart in the
regulation at sigB and a stationary-phase component that is
shared by the sigB promoter.
Our Western blot analyses also revealed that the rsbW313
mutation reduced &e abundance to less than 10% of that seen
in a strain with a wild-type rsbW allele (Fig. 5). The overlap
between the rsbW and sigB genes (26) suggests that this
reduction in &r levels may be due to reduced translation of
sigB in the absence of a fully translated rsbWgene; however,
other explanations are possible. &e and RsbW appear to
form a complex within the cell (5). Therefore, in the absence
of RsbW, &e may be more susceptible to degradation.
Pulse-chase experiments will be needed to distinguish be-
tween potential roles for rsbW in eB synthesis or stabiliza-
tion.
The function of RsbX in a1 regulation is not clear. Unlike
the RsbW-RsbV pair, RsbX has no apparent effect on e
activity when the sigB operon is expressed from PSPAC-
Although this finding suggests that RsbX controls &-' expres-
sion but not its activation state, such a notion is not easily
reconciled with the observation that &3-dependent promot-
ers are expressed at very high levels in RsbX- RsbW+
RsbV+ strains. It would be expected that if a loss of RsbX
merely elevated the expression of the sigB operon, the
coordinately enhanced synthesis of RsbW would continue to
inhibit &e. The apparent failure of RsbW to inhibit a' in
RsbX- strains could be rationalized by assuming a need for
an additional factor to maintain the inhibition. If the sigB
operon is expressed at high levels, as it is in RsbX- strains,
there may be insufficient amounts of this factor present to
prevent the RsbV-dependent inactivation of RsbW. Al-
though such a possibility seems plausible, it is unlikely to be
true in its simplest form. A comparison of the -B protein
levels detectable by Western blot analysis reveals that a fully
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induced PSpAc-driven sigB operon produces approximately
half as much o-' as that formed in an RsbX- strain that
expresses sigB from its normal r'3-dependent promoter and
5- to 10-fold more oB than that seen in strains with a
wild-type sigB locus (data not shown). This implies that
high-level expression of the sigB operon alone is insufficient
to account for the RsbX- phenotype. Models to account for
these results would be highly speculative and should await
more experimental data; however, it does appear that spe-
cific inhibition of sigB operon expression is unlikely to be the
only function of RsbX. What its other functions may be and
how they ultimately influence &rB activation remain a mys-
tery.
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